patritumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for patritumab, covering 2018-01-23 to 2019-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN ) [Phase 2]